Innovations across Drug Re-profiling - Genetic Technology TOE

USD 250.00

* Required Fields

USD 250.00

PAY BY INVOICE

Be the first to review this product

This edition of the Genetic Technology TOE depicts the current landscape and the new life sciences trends across drug re-profiling. In the study, different enabling technologies used for drug re-profiling, such as machine learning and computational biology approaches are described. The corresponding patent scenario is depicted, along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest develo

Table of Contents

Innovations across Drug Re-profiling - Genetic Technology TOETechnology ProfilesUsing Machine Learning and Computational Bioinformatics for Drug Re-profiling Smarter Drug Profiling Using Pharmacological Data and Computational TechniquesUsing in vivo Phenotypic Screening for Drug RepositioningComputer Simulation of CNS Disorders for Drug Re-profilingAppendixPatent ScenarioPatent ScenarioIndustry Interactions




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.